Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 80
Selected: 0
NCT IDTitle
NCT04625361Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects
NCT05060822Phase ll Study of HEC585 in Patients With IPF
NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
NCT04422496The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
NCT05454098Clifutinib Food Effect Study in Healthy Subjects
NCT05391360Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
NCT03886688HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
NCT04324372Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
NCT04577703First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors
NCT04147208Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
NCT03458481Phase 2 Study of Yimitasvir Phosphate Capsules
NCT04925674Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
NCT04591301The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
NCT04536532Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
NCT07102251A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
NCT03662568A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
NCT04623814the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT05504876Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NCT03876925A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
NCT05802862A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China
NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
NCT03487107Phase 3 Study of Yimitasvir Phosphate Capsules
NCT03663686The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
NCT03462173The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
NCT05383131To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
NCT07211165Clinical Study on the Mass Balance of Clifutinib
NCT05492630Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects
NCT07082842Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT03502902The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT05427682A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage
NCT07341672A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT04925661HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
NCT03655873The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
NCT04131192Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT03638076The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
NCT04992858Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
NCT03673696The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
NCT04546984Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
NCT04551261GLS4/RTV and TAF Drug-drug Interaction
NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
NCT05451602HEC169096 in Participants With Advanced Solid Tumors
NCT05576298A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects
NCT04202952The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
NCT05586074HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT05998304ADME Study of [14C] Yiqibuvir in Healthy Male Subjects
NCT03811678The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
NCT05133882A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
NCT05109078ADME Study of [14C]- Rongliflozin in Healthy Male Subjects